214 related articles for article (PubMed ID: 20382692)
1. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84).
Wesseling-Perry K; Harkins GC; Wang HJ; Elashoff R; Gales B; Horwitz MJ; Stewart AF; Jüppner H; Salusky IB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2772-80. PubMed ID: 20382692
[TBL] [Abstract][Full Text] [Related]
2. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
[TBL] [Abstract][Full Text] [Related]
3. Lack of FGF23 response to acute changes in serum calcium and PTH in humans.
Wesseling-Perry K; Wang H; Elashoff R; Gales B; Jüppner H; Salusky IB
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1951-6. PubMed ID: 25062462
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus.
Bover J; Jara A; Trinidad P; Rodriguez M; Felsenfeld AJ
Bone; 1999 Sep; 25(3):279-85. PubMed ID: 10495131
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
[TBL] [Abstract][Full Text] [Related]
6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
7. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.
Wesseling-Perry K; Pereira RC; Wang H; Elashoff RM; Sahney S; Gales B; Jüppner H; Salusky IB
J Clin Endocrinol Metab; 2009 Feb; 94(2):511-7. PubMed ID: 19050056
[TBL] [Abstract][Full Text] [Related]
11. Effect of haemodialysis on markers of bone turnover in children.
Waller S; Ridout D; Rees L
Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
[TBL] [Abstract][Full Text] [Related]
13. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
[TBL] [Abstract][Full Text] [Related]
14. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
15. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy.
Rodriguez M; Felsenfeld AJ; Llach F
Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
17. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
Horwitz MJ; Tedesco MB; Sereika SM; Prebehala L; Gundberg CM; Hollis BW; Bisello A; Garcia-Ocaña A; Carneiro RM; Stewart AF
J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
[TBL] [Abstract][Full Text] [Related]
18. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients.
Ghosh-Narang J; Jones TM; Menke A; Todd AC; Muntner P; Batuman V
Am J Med Sci; 2007 Dec; 334(6):415-20. PubMed ID: 18091361
[TBL] [Abstract][Full Text] [Related]
20. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
